Furthermore, the anti-obesity benefits of artesunate were shown to require GDF15 signaling, as gene deletion of GFRAL or cell-type-specific silencing of GDF15 abolished its metabolic effects [145]. The gene discussed is GFRAL; the disease is obesity disorder.